Although not yet demonstrated at the molecular level, dysregulated cellular levels of Miro1 have been described in ALS animal models and in patients (Zhang et al., 2015; Moller et al., 2017). This evidence concerns the gene RHOT1 and amyotrophic lateral sclerosis.